138 related articles for article (PubMed ID: 2054213)
1. [An analysis of hospital bacterial infections in cirrhotic patients undergoing selective intestinal decontamination].
Tomás A; Soriano G; Guarner C; Teixidó M; Méndez C; Tena F; Fábrega E; Villanueva C; Such J; Balanzó J
Rev Esp Enferm Dig; 1991 Apr; 79(4):259-64. PubMed ID: 2054213
[TBL] [Abstract][Full Text] [Related]
2. Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin.
Novella M; Solà R; Soriano G; Andreu M; Gana J; Ortiz J; Coll S; Sàbat M; Vila MC; Guarner C; Vilardell F
Hepatology; 1997 Mar; 25(3):532-6. PubMed ID: 9049193
[TBL] [Abstract][Full Text] [Related]
3. [Variation of C3 in ascitic fluid from cirrhotic patients subjected to intestinal sterilization or selective intestinal decontamination].
Soriano G; Teixidó M; Guarner C; Such J; Espinós JC; Sainz S; Enríquez J; Rodríguez JL; Vilardell F
Rev Esp Enferm Apar Dig; 1989 Feb; 75(2):123-6. PubMed ID: 2710995
[TBL] [Abstract][Full Text] [Related]
4. Parenteral antibiotic prophylaxis of bacterial infections does not improve cost-efficacy of oral norfloxacin in cirrhotic patients with gastrointestinal bleeding.
Sàbat M; Kolle L; Soriano G; Ortiz J; Pamplona J; Novella MT; Villanueva C; Sainz S; Torras J; Balanzó J; Guarner C
Am J Gastroenterol; 1998 Dec; 93(12):2457-62. PubMed ID: 9860409
[TBL] [Abstract][Full Text] [Related]
5. Infections caused by Escherichia coli resistant to norfloxacin in hospitalized cirrhotic patients.
Ortiz J; Vila MC; Soriano G; Miñana J; Gana J; Mirelis B; Novella MT; Coll S; Sábat M; Andreu M; Prats G; Solá R; Guarner C
Hepatology; 1999 Apr; 29(4):1064-9. PubMed ID: 10094947
[TBL] [Abstract][Full Text] [Related]
6. Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage.
Fernández J; Ruiz del Arbol L; Gómez C; Durandez R; Serradilla R; Guarner C; Planas R; Arroyo V; Navasa M
Gastroenterology; 2006 Oct; 131(4):1049-56; quiz 1285. PubMed ID: 17030175
[TBL] [Abstract][Full Text] [Related]
7. [Incidence of spontaneous bacterial peritonitis in cirrhotic patients with ascites. A two-year prospective study].
Osztrogonácz H; Horváth G; Tolvaj G; Machó M; Bauer E; Dávid K
Orv Hetil; 1996 Jan; 137(4):179-82. PubMed ID: 8721832
[TBL] [Abstract][Full Text] [Related]
8. [The duration of the effect of norfloxacin on the fecal flora in cirrhosis patients].
Soriano G; Guarner C; Tomás A; Anguera A; Mirelis B; Fernández C; Herrero M; Alonso C; Vilardell F
Rev Esp Enferm Dig; 1992 May; 81(5):322-6. PubMed ID: 1616740
[TBL] [Abstract][Full Text] [Related]
9. Selective intestinal decontamination prevents spontaneous bacterial peritonitis.
Soriano G; Guarner C; Teixidó M; Such J; Barrios J; Enríquez J; Vilardell F
Gastroenterology; 1991 Feb; 100(2):477-81. PubMed ID: 1985045
[TBL] [Abstract][Full Text] [Related]
10. Effect of selective bowel decontamination with norfloxacin on spontaneous bacterial peritonitis, translocation, and survival in an animal model of cirrhosis.
Runyon BA; Borzio M; Young S; Squier SU; Guarner C; Runyon MA
Hepatology; 1995 Jun; 21(6):1719-24. PubMed ID: 7768517
[TBL] [Abstract][Full Text] [Related]
11. [Prophylaxis of infectious complications by selective digestive bacterial decontamination in patients with cirrhosis].
Grangé JD; Amiot X
Gastroenterol Clin Biol; 1992; 16(8-9):692-700. PubMed ID: 1426826
[No Abstract] [Full Text] [Related]
12. Selective intestinal decontamination with norfloxacin reduces bacterial translocation in ascitic cirrhotic rats exposed to hemorrhagic shock.
Llovet JM; Bartolí R; Planas R; Viñado B; Pérez J; Cabré E; Arnal J; Ojanguren I; Ausina V; Gassull MA
Hepatology; 1996 Apr; 23(4):781-7. PubMed ID: 8666332
[TBL] [Abstract][Full Text] [Related]
13. [Bacterial infections in liver cirrhosis].
Papp M; Farkas A; Udvardy M; Tornai I
Orv Hetil; 2007 Mar; 148(9):387-95. PubMed ID: 17344166
[TBL] [Abstract][Full Text] [Related]
14. Bacterial infections in liver disease.
Navasa M; Rimola A; Rodés J
Semin Liver Dis; 1997; 17(4):323-33. PubMed ID: 9408968
[TBL] [Abstract][Full Text] [Related]
15. Norfloxacin and cisapride combination decreases the incidence of spontaneous bacterial peritonitis in cirrhotic ascites.
Itha S; Sharma A; Bhatt G
J Gastroenterol Hepatol; 2006 Oct; 21(10):1634. PubMed ID: 16928235
[No Abstract] [Full Text] [Related]
16. [Spontaneous bacterial peritonitis (SBP): prevalence and characteristics in a population of 314 cirrhotic patients evaluated at hospital admission].
Marelli A; Nardecchia L; De Gennaro F; Bodini P
Minerva Med; 1999 Oct; 90(10):369-75. PubMed ID: 10767910
[TBL] [Abstract][Full Text] [Related]
17. Systemic antibiotic prophylaxis after gastrointestinal hemorrhage in cirrhotic patients with a high risk of infection.
Pauwels A; Mostefa-Kara N; Debenes B; Degoutte E; Lévy VG
Hepatology; 1996 Oct; 24(4):802-6. PubMed ID: 8855179
[TBL] [Abstract][Full Text] [Related]
18. [A microbiological and clinical study of 57 cases of spontaneous bacterial peritonitis in liver cirrhosis patients].
Sáez-Royuela F; Gómez Rubio M; Fernández Guerrero ML; Díaz Curiel M; Hernández Guio C
Rev Clin Esp; 1990 Nov; 187(7):321-4. PubMed ID: 2091110
[TBL] [Abstract][Full Text] [Related]
19. [Development of Escherichia coli strands resistant to quinolones in stools of patients with liver cirrhosis submitted to selective bowel decontamination].
Aparicio JR; Such J; Gutiérrez A; Pérez-Mateo M; Plaza J; Arroyo A
Med Clin (Barc); 1999 Sep; 113(7):241-5. PubMed ID: 10544377
[TBL] [Abstract][Full Text] [Related]
20. Intestinal bacterial overgrowth in liver cirrhosis: is it a predisposing X factor for spontaneous ascitic infection?
Karaca C; Kaymakoglu S; Uyar A; Karayay S; Gurler N; Demir K; Dincer D; Tuncer L; Boztas G; Cakaloglu Y; Okten A
Am J Gastroenterol; 2002 Jul; 97(7):1851. PubMed ID: 12135057
[No Abstract] [Full Text] [Related]
[Next] [New Search]
